Oppenheimer & Co. Inc. trimmed its stake in Ambev S.A. (NYSE:ABEV - Free Report) by 97.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,627 shares of the company's stock after selling 755,732 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in Ambev were worth $43,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. NewEdge Advisors LLC boosted its stake in Ambev by 51.4% during the fourth quarter. NewEdge Advisors LLC now owns 17,084 shares of the company's stock valued at $32,000 after buying an additional 5,798 shares during the last quarter. Mondrian Investment Partners LTD increased its holdings in Ambev by 40.4% during the 4th quarter. Mondrian Investment Partners LTD now owns 20,810 shares of the company's stock worth $38,000 after purchasing an additional 5,993 shares during the period. Jones Financial Companies Lllp increased its holdings in Ambev by 7.8% during the 4th quarter. Jones Financial Companies Lllp now owns 85,142 shares of the company's stock worth $158,000 after purchasing an additional 6,164 shares during the period. PDS Planning Inc increased its holdings in Ambev by 18.3% during the 4th quarter. PDS Planning Inc now owns 41,244 shares of the company's stock worth $76,000 after purchasing an additional 6,374 shares during the period. Finally, Insigneo Advisory Services LLC increased its holdings in shares of Ambev by 22.1% in the 1st quarter. Insigneo Advisory Services LLC now owns 38,457 shares of the company's stock valued at $90,000 after acquiring an additional 6,949 shares during the period. 8.13% of the stock is owned by institutional investors.
Ambev Price Performance
Shares of ABEV opened at $2.49 on Friday. Ambev S.A. has a fifty-two week low of $1.76 and a fifty-two week high of $2.64. The company has a market capitalization of $39.16 billion, a price-to-earnings ratio of 15.53, a price-to-earnings-growth ratio of 2.62 and a beta of 0.74. The firm has a 50-day simple moving average of $2.47 and a 200-day simple moving average of $2.20. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.80 and a current ratio of 1.11.
Ambev (NYSE:ABEV - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.04 EPS for the quarter, meeting analysts' consensus estimates of $0.04. The firm had revenue of $3.92 billion during the quarter, compared to the consensus estimate of $22.40 billion. Ambev had a net margin of 15.76% and a return on equity of 14.74%. On average, equities research analysts anticipate that Ambev S.A. will post 0.18 earnings per share for the current year.
Ambev Cuts Dividend
The company also recently disclosed a -- dividend, which will be paid on Thursday, July 17th. Investors of record on Monday, May 19th will be given a $0.0219 dividend. The ex-dividend date of this dividend is Monday, May 19th. This represents a yield of 5%. Ambev's payout ratio is currently 68.75%.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the company. Morgan Stanley cut Ambev from an "equal weight" rating to an "underweight" rating in a research report on Monday, April 7th. Wall Street Zen initiated coverage on Ambev in a research note on Wednesday, April 23rd. They issued a "buy" rating for the company. UBS Group boosted their price objective on Ambev from $2.60 to $2.70 and gave the stock a "neutral" rating in a research note on Wednesday, June 4th. Finally, Barclays boosted their price objective on Ambev from $2.00 to $2.50 and gave the stock an "equal weight" rating in a research note on Monday, May 12th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $2.60.
View Our Latest Stock Analysis on ABEV
Ambev Company Profile
(
Free Report)
Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ambev, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.
While Ambev currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report